Donor Login
Contact Us
JDRF
About
Investment Strategy
Portfolio
Our People
Venture Philanthropy
News
Donor Login
Get in touch
News and Press
i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules
January 06, 2022 |
BOSTON, MA
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin
November 02, 2021 |
SAN DIEGO, CA
i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman
October 12, 2021 |
BOSTON, MA
SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
September 13, 2021 |
WATERTOWN, MA
Inversago Pharma Initiates a Phase 1 Clinical Trial on INV-202, a Next Generation Peripherally-acting CB1 Blocker
September 07, 2021 |
MONTREAL
